Seagen Inc.
CD19 binding agents and uses thereof
Last updated:
Abstract:
This invention, among other things, relates to CD19 binding agents and methods of using such CD binding agents for treating disease.
Status:
Grant
Type:
Utility
Filling date:
14 Feb 2018
Issue date:
17 May 2022